Published in BMJ Open on January 28, 2016
Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies. Pharmacoepidemiol Drug Saf (2016) 0.77
Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt. Drug Saf (2017) 0.75
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol (2015) 4.87
Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf (2012) 4.71
Tutorial in biostatistics: the self-controlled case series method. Stat Med (2006) 4.12
Relative incidence estimation from case series for vaccine safety evaluation. Biometrics (1995) 2.55
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant (2011) 2.28
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant (2007) 1.83
Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis (2012) 1.73
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust (2012) 1.45
Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics (2008) 1.43
The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Transpl Int (2011) 1.43
Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol (2011) 1.26
Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant (2009) 1.20
Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation (2010) 1.02
Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine (2013) 0.98
Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant (2011) 0.98
Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect (2011) 0.96
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis (2012) 0.95
Studies using English administrative data (Hospital Episode Statistics) to assess health-care outcomes--systematic review and recommendations for reporting. Eur J Public Health (2012) 0.95
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91
Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine (2011) 0.89
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS One (2014) 0.89
Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients. Nephrol Dial Transplant (2011) 0.88
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther (2012) 0.87
Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant (2005) 0.86
Influenza vaccination in liver transplant recipients. Transplantation (1999) 0.85
Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation (2010) 0.84
Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study. J Pediatr (2015) 0.84
Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant (2011) 0.84
Influenza vaccination in immunocompromised patients: efficacy and safety. Immunotherapy (2014) 0.83
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol (2011) 0.83
Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatr Transplant (2010) 0.82
Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. J Heart Lung Transplant (2010) 0.82
Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol (2011) 0.82
Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation (2011) 0.82
Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant (2011) 0.82
Influenza vaccination in solid-organ transplant recipients. Curr Opin Organ Transplant (2012) 0.81
Clinical manifestations and evolution of infection by influenza A (H1N1) in kidney transplant recipients. J Bras Nefrol (2011) 0.80
Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: a report of two cases. Transpl Int (2010) 0.79
Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients. Transpl Infect Dis (2012) 0.79
Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine (2011) 0.79
Acceptance and adverse events of the 2009 H1N1 vaccination in immunosuppressed pediatric liver transplant recipients. J Pediatr (2010) 0.79
Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis (2012) 0.78
H1N1 influenza vaccination and infection in pediatric heart transplants. J Heart Lung Transplant (2010) 0.78
Correlations between A/H1N1 influenza and acute cellular rejection in liver transplantation patients. Transplant Proc (2010) 0.77
Immunization in transplantation: review of the recent literature. Curr Opin Organ Transplant (2013) 0.76
[H1N1 (2009) influenza A infection in transplant recipient patients: a comparative study versus non-transplanted patients]. Rev Pneumol Clin (2011) 0.76